67 related articles for article (PubMed ID: 238542)
21. [Ethaverin, a coronary dilator with beta-receptor depressing and antiarrhythmia myocardial effects].
Fleckenstein A; Grün G; Döring HJ; Haastert HP; Tritthart H
Med Welt; 1973 Mar; 24(12):441-9. PubMed ID: 4144783
[No Abstract] [Full Text] [Related]
22. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
Zausig YA; Stowe DF; Zink W; Grube C; Martin E; Graf BM
Anesth Analg; 2006 Jun; 102(6):1646-52. PubMed ID: 16717301
[TBL] [Abstract][Full Text] [Related]
23. [Adenosine-3',5'-monophosphate content and muscle tension in isolated coronary arteries under the effect of lanthanum ions].
Fermum R; Möritz KU; Schäfer U; Leibelt M
Biomed Biochim Acta; 1984; 43(11):1285-94. PubMed ID: 6085268
[TBL] [Abstract][Full Text] [Related]
24. Beta-adrenoceptor blocking effects of two bopindolol metabolites in isolated guinea-pig atria.
Brasch H; Dominiak P
Arzneimittelforschung; 1992 Feb; 42(2):97-100. PubMed ID: 1351728
[TBL] [Abstract][Full Text] [Related]
25. Potentation of the cardiac response to aminophylline by oxyfedrine.
Sakai K; Pöch G; Kukovetz WR
Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(1):11-22. PubMed ID: 163989
[TBL] [Abstract][Full Text] [Related]
26. Evidence that prazosin disturbs isoprenaline positive inotropic action in the guinea pig heart papillary muscle.
Kocić I
Pol J Pharmacol; 1996; 48(4):447-52. PubMed ID: 9112686
[TBL] [Abstract][Full Text] [Related]
27. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
28. Coronary and aortic vasoconstriction by cathinone, the active constituent of khat.
Al-Motarreb AL; Broadley KJ
Auton Autacoid Pharmacol; 2003; 23(5-6):319-26. PubMed ID: 15255816
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
30. [Effect of INH on coronary arteries and heart action in experimental tuberculosis].
Dettlaff Z
Gruzlica; 1971 Dec; 39(12):1172-9. PubMed ID: 5139236
[No Abstract] [Full Text] [Related]
31. Effects of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626), a new phosphodiesterase inhibitor, on the cardiovascular system of the dog.
Furuta Y; Takahira T; Ueno M
Arzneimittelforschung; 1985; 35(5):827-32. PubMed ID: 4026906
[TBL] [Abstract][Full Text] [Related]
32. Effects of dobutamine on coronary circulation and cardiac metabolism of the dog.
Sakanashi M; Tomomatsu E; Takeo S; Araki H; Iwasaki K; Sakamoto K; Takenaka F
Arzneimittelforschung; 1978; 28(5):798-801. PubMed ID: 581958
[TBL] [Abstract][Full Text] [Related]
33. Myocardial effects of flavonoids from Crataegus species.
Schüssler M; Hölzl J; Fricke U
Arzneimittelforschung; 1995 Aug; 45(8):842-5. PubMed ID: 7575743
[TBL] [Abstract][Full Text] [Related]
34. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
[TBL] [Abstract][Full Text] [Related]
35. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.
Burke JA; Levi R; Guo ZG; Corey EJ
J Pharmacol Exp Ther; 1982 Apr; 221(1):235-41. PubMed ID: 6278136
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacological and toxicological studies on the effect characterization of etafenone].
Hapke HJ; Sterner W
Arzneimittelforschung; 1969 Oct; 19(10):1664-72. PubMed ID: 5395365
[No Abstract] [Full Text] [Related]
37. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
38. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.
Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H
J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891
[TBL] [Abstract][Full Text] [Related]
39. Effects of etafenone on myocardial energy metabolism as studied by an organ redoximeter and biochemical analyses.
Etoh Y; Nakazawa M; Imai S
Jpn J Pharmacol; 1984 Jul; 35(3):229-35. PubMed ID: 6482088
[TBL] [Abstract][Full Text] [Related]
40. An analysis of the B-adrenergic action of oxyfedrine.
Sakai K; Shiraki Y; Hashimoto K
Eur J Pharmacol; 1973 Jan; 21(1):81-8. PubMed ID: 4145385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
